Research Paper Volume 12, Issue 1 pp 965—977

Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set

Figure 1. Flowchart of the study. A total of 903 HCC patients from five separate datasets were included in the analysis. We developed the immune-based prognostic signature for HCC (IPSHCC) using the training dataset and validated it in five independent validation subsets. We also integrated IPSHCC with stage, invasion, age, and gender to improve its prognostic value.